Welcome to the LinkedIn page of AGUETTANT DACH!
AGUETTANT is a French family-owned pharmaceutical company dedicated to the development, manufacture and marketing of injectable pharmaceuticals used or administered in hospitals.
AGUETTANT puts its know-how at the service of progress and medical innovation to shape the therapeutic solutions of tomorrow.
Our vision is to create real added value through our innovations. We want to redefine safety and quality standards for medicines in order to minimize medication risks for users and patients.
On this page you will find all the news from AGUETTANT DACH.
Company Details
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- sterile Fertigspritzen, RTA, RTU, Anästhesie, Intensivmedizin, Notfallmedizin, Onkologie, Infusion, Sichere Infusion, Standardinfusionstherapie, Medizinprodukte, Injizierbare Wirkstoffe, Reanimation, Notfall-Injektionen, Parkinson-Krankheit und Spastik, verschreibungspflichtige Medikamente, Intensivmedizin.
Aguettant Dach Questions
Aguettant Dach's LinkedIn profile is https://www.linkedin.com/company/aguettant-dach
Aguettant Dach's industry is
Pharmaceutical Manufacturing
Aguettant Dach's top competitors are
Specific Pharma A/s,
Kiadis Pharma N.v.,
Pharma-Tenders,
Ace Pharmaceuticals,
Amonita Gmbh,
Laboratoire Aguettant,
2care4 Group,
Aguettant Deutschland Gmbh,
Abacus Medicine Pharma Services,
Aguettant Benelux.
Aguettant Dach's categories are Pharmaceutical Manufacturing
Aguettant Dach's founding year is 2023
